|
HY-15608-50mg
|
MedChemexpress LLC
|
MPTP (hydrochloride) [CAS 23007-85-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15608-500mg
|
MedChemexpress LLC
|
MPTP (hydrochloride) [CAS 23007-85-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15608-1mL
|
MedChemexpress LLC
|
MPTP (hydrochloride) [CAS 23007-85-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P70220-10ug
|
MedChemexpress LLC
|
MPZL1, Human (HEK293, His)
|
|
|
|
|
HY-P70220-50ug
|
MedChemexpress LLC
|
MPZL1, Human (HEK293, His)
|
|
|
|
|
HY-P3304-10mg
|
MedChemexpress LLC
|
MR 409 [CAS 1445155-39-4]
|
|
Cancer-programmed cell death
|
|
|
HY-P3304-5mg
|
MedChemexpress LLC
|
MR 409 [CAS 1445155-39-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-1mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-10mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-100mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-25mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-5mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-50mg
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1]
|
|
Cancer-programmed cell death
|
|
|
HY-138283-1mL
|
MedChemexpress LLC
|
MR837 [CAS 1210906-48-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-103178-5mg
|
MedChemexpress LLC
|
MRE3008F20 [CAS 252979-43-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-10mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-5mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-50mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-1mL
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-14174-10mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-100mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-5mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-50mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-1mL
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
